MedPath

The use of vaginal iso sorbide mononitrate to make the uterine cervix more favourable for induction of labour

Not Applicable
Conditions
Effects of vaginal Iso Sorbide Mononitrate (ISMN) for pre induction cervical ripening
Registration Number
SLCTR/2007/009
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow up complete
Sex
Not specified
Target Recruitment
156
Inclusion Criteria

Consecutive women with uncomplicated singleton pregnancies with cephalic presentation between 40 weeks + 5 days to 41 weeks of period of amenorrhea where the dates have been confirmed by an early ultrasound scan and having a modified Bishop score 5

Exclusion Criteria

Subjects with any medical or obstetric complications or any contraindication for the use of ISMN will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pulse Rate, Blood Pressure, Resistance Index, Pulsatality Index at 180 & 360 minutes & 48 hrs ,Modified Bishop Score at 375 minutes Cardiotocographs and Fetal Acoustic Stimulation Test results ,proportions establishing Spontaneous labour or becoming favourable for induction of labour or needing caesarean section within 48 hrs of the therapy ,and mode of delivery, interval and the five minute Apgar Scores of babies delivered within 72 hours of initial therapy []<br>
Secondary Outcome Measures
NameTimeMethod
Side effects of the ISMN ( headache, nausea, palpitations, hot flushes, abdominal pain, pelvic pain ) []<br>
© Copyright 2025. All Rights Reserved by MedPath